Clinical trial · Interventional
The Economic Impact of the Pancreatography in the Endoscopic Treatment of Pancreatic Pseudocysts
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Pancreatic pseudocysts (PP) present as a complication that occurs in 5-15% of acute pancreatitis and 26-40% of chronic pancreatitis (1-3). To date the endoscopic drainage with endoscopic ultrasound (EUS) has replace the surgical treatment due to the similar success and complication rate but with a lower cost and short hospital stay (4-6). Regarding recurrence, it is important to know the anatomy of the main pancreatic duct (MPD). For this purpose, the endoscopic retrograde pancreatography (ERP) has been describe as a useful tool. In fact, many authors perform it before the endoscopic drainage while others wait several weeks after the drainage (7-9) with similar technical success (5,8). However, there are no studies that compare the technical difficulty and the total cost between these two approaches.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Pancreatic Duct Disorder | — | UNRESOLVED | — |
| Pseudocyst Pancreas | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Endoscopic retrograde pancreatography | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Same day
- description
- The ERP will be performed the same day of the endoscopic drainage of PP
- interventionNames
- Procedure: Endoscopic retrograde pancreatography
- type
- ACTIVE_COMPARATOR
- label
- Other day
- description
- The ERP will be performed 6 weeks after the endoscopic drainage of PP.
- interventionNames
- Procedure: Endoscopic retrograde pancreatography
Primary outcomes (1)
- measure
- The impact of the pancreatography in the endoscopic treatment of pancreatic pseudocysts
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 19 Years
Show eligibility criteria text
Inclusion Criteria: 1. Pancreatic pseudocyst that fulfilled the Atlanta Classification 2. Symptomatic pancreatic pseudocyst 3. Informed consent obtained Exclusion Criteria: 1. Patient unwilling to participate 2. Absence of duration time of the pancreatography procedure in the record 3. Absence of the number of weeks between the drainage and the pancreatography
References
Publications (0)
Data not yet available